Biobanking Market Trends

  • Report ID: 4602
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Biobanking Market Trends

Growth Drivers

  • Growing Research Activities Associated with Genomics - As per the World Health Organization (WHO), as a result of significant investments made during the COVID-19 pandemic, the percentage of countries capable of carrying out genomic surveillance expanded from 54% to 68% between March 2021 and January 2022.

  • Genomics research is the study of full genetics along with the complement of an organism. It is generally conducted to prepare personalized medicines and focus on the editing, mapping, structure, function, and evolution of a genome. Furthermore, there has been growing popularity of genomics in cancer care for providing personalized medicines to the patients for the cure. In addition, genomic research can obtain several public targets, such as a reduction in health disparities. Therefore, the surge in genomics research is expected to fuel market growth over the forecast period.
  • Increasing Instances of Umbilical Cord Blood Cell Conservation – For instance, in Japan, approximately 36% of childbirth facilities presently provide umbilical cord blood cell storage to private biobanks, which is an increase from 15% in the past.

  • Escalating Count of Biobanks Globally - For instance, the worldwide number of biobanks reached around 130 by the end of 2018. Hence, the surge in the number of biobanks is expected to enlarge the market size over the forecast period.

  • Rising Cases of Hemophilia and Bleeding Disorders - Hemophilia is a disorder that interrupts the clotting of blood. It is a rare disorder that can develop in humans based on their genetics. For instance, between 2021 to 2022, approximately 200 thousand people were noticed to be living with hemophilia across the globe.

Challenges

  • Associated High Cost of Storage of Specimen Samples - The process of specimen sample storage in biobanks requires costly equipment, which in turn, makes the entire process of storage expensive. This factor is estimated to hinder the growth of the biobanking market.
  • Deficit in Counselling and Training on Medical Ethics
  • Misconceptions about Biobanking

Biobanking Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~8%

Base Year Market Size (2022)

~ USD 50 Billion

Forecast Year Market Size (2033)

~ USD 90 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

8.2%

Base Year Market Size (2024)

USD 58.78 billion

Forecast Year Market Size (2037)

USD 165.2 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4602
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of biobanking is estimated at USD 62.68 billion.

The biobanking market size was over USD 58.78 billion in 2024 and is projected to cross USD 165.2 billion by the end of 2037, witnessing more than 8.2% CAGR during the forecast period i.e., between 2025-2037. Increasing instances of umbilical cord blood cell conservation will boost the market growth.

North America is poised to hold largest industry share by 2037, attributed to rising adoption of advanced technology, along with growing awareness regarding biobanking among the people and research professionals, and the escalating investment in research and development activities in the region.

The major players in the market include UK Biobank Limited, Thermo Fisher Scientific Holdings, Inc., Tecan Trading AG, Hamilton Bonaduz AG, Bay Biosciences LLC., ISENET USA LLC, ASKION GmbH, Promega Corporation, VWR International, LLC., Merck KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample